Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles

Código QR

Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles

Christine Rangger,1 Anna Helbok,1 Elisabeth von Guggenberg,1 Jane Sosabowski,2 Thorsten Radolf,3 Ruth Prassl,4 Fritz Andreae,3 Gudrun C Thurner,5 Roland Haubner,1 Clemens Decristoforo11Department of Nuclear Medicine, Innsbruck Medical University, Innsbruck, Austria; 2Center for Molecular Oncology, B...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Rangger C, Helbok A, von Guggenberg E, Sosabowski J, Radolf T, Prassl R, Andreae F, Thurner GC, Haubner R, Decristoforo C
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/a1340052aa2845cf819c9c9c907822e7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Tumor targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticles
por: Rangger C, et al.
Publicado: (2013)

Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma
por: Wei MY, et al.
Publicado: (2015)

Folate receptor targeting of radiolabeled liposomes reduces intratumoral liposome accumulation in human KB carcinoma xenografts
por: Christensen E, et al.
Publicado: (2018)

Interactions of primaquine and chloroquine with PEGylated phosphatidylcholine liposomes
por: Andang Miatmoko, et al.
Publicado: (2021)

Treatment of neuroblastoma and rhabdomyosarcoma using RGD-modified liposomal formulations of patupilone (EPO906)
por: Scherzinger-Laude K, et al.
Publicado: (2013)

Radiolabeled Bombesin Analogs
por: Rosalba Mansi, et al.
Publicado: (2021)

Mechanistic study of decreased skin penetration using a combination of sonophoresis with sodium fluorescein-loaded PEGylated liposomes with D-limonene
por: Rangsimawong W, et al.
Publicado: (2015)

The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia
por: Rivka Yatuv, et al.
Publicado: (2010)

The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation
por: Yu KF, et al.
Publicado: (2013)

Renal-targeted delivery of triptolide by entrapment in pegylated TRX-20-modified liposomes
por: Yuan Z, et al.
Publicado: (2017)

Improvement of intratumor microdistribution of PEGylated liposome via tumor priming by metronomic S-1 dosing
por: Doi Y, et al.
Publicado: (2016)

Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi&rsquo;s sarcoma
por: Francesca Cainelli, et al.
Publicado: (2009)

Physical PEGylation Enhances The Cytotoxicity Of 5-Fluorouracil-Loaded PLGA And PCL Nanoparticles
por: Ashour AE, et al.
Publicado: (2019)

Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides
por: Sun J, et al.
Publicado: (2017)

Echogenic PEGylated PEI-Loaded Microbubble As Efficient Gene Delivery System
por: Liufu C, et al.
Publicado: (2019)

iRGD Peptide-Mediated Liposomal Nanoparticles with Photoacoustic/Ultrasound Dual-Modality Imaging for Precision Theranostics Against Hepatocellular Carcinoma
por: Li H, et al.
Publicado: (2021)

PEGylated apoptotic protein-loaded PLGA microspheres for cancer therapy
por: Byeon HJ, et al.
Publicado: (2015)

Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging
por: Adrian Chrastina, et al.
Publicado: (2010)

99mTc Radiolabeled HA/TPGS-Based Curcumin-Loaded Nanoparticle for Breast Cancer Synergistic Theranostics: Design, in vitro and in vivo Evaluation
por: Huang C, et al.
Publicado: (2020)

Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan
por: Lieke Joosten, et al.
Publicado: (2017)

Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries
por: Jain PP, et al.
Publicado: (2014)

Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome–Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive Liposomes
por: Petrini M, et al.
Publicado: (2021)

Reactive Oxygen Species-Mediated Inflammation and Apoptosis in Hand-Foot Syndrome Induced by PEGylated Liposomal Doxorubicin
por: Hu X, et al.
Publicado: (2021)

Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors
por: Wu H, et al.
Publicado: (2015)

Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells
por: Chen CW, et al.
Publicado: (2011)

Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats
por: Chen Z, et al.
Publicado: (2012)

Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects
por: Song Z, et al.
Publicado: (2017)

Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid–paclitaxel (CLA-PTX) on B16-F10 melanoma
por: Du R, et al.
Publicado: (2014)

Luteinizing hormone-releasing hormone receptor-mediated delivery of mitoxantrone using LHRH analogs modified with PEGylated liposomes
por: Yingna He, et al.
Publicado: (2010)

Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors [Corrigendum]
por: Wu H, et al.
Publicado: (2019)

Vitamin C-driven epirubicin loading into liposomes
por: Lipka D, et al.
Publicado: (2013)

Preparation and in vitro and in vivo characterization of cyclosporin A-loaded, PEGylated chitosan-modified, lipid-based nanoparticles
por: Zhang L, et al.
Publicado: (2013)

Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101).
por: Pieter J Gaillard, et al.
Publicado: (2014)

Accelerated drug release and clearance of PEGylated epirubicin liposomes following repeated injections: a new challenge for sequential low-dose chemotherapy
por: Yang Q, et al.
Publicado: (2013)

Higher efficacy and reduced adverse reactions in neoadjuvant chemotherapy for breast cancer by using pegylated liposomal doxorubicin compared with pirarubicin
por: Weifang Liu, et al.
Publicado: (2021)

Photodynamic therapy with conventional and PEGylated liposomal formulations of mTHPC (temoporfin): comparison of treatment efficacy and distribution characteristics in vivo
por: Reshetov V, et al.
Publicado: (2013)

Gemcitabine-loaded liposomes: rationale, potentialities and future perspectives
por: Federico C, et al.
Publicado: (2012)

Strategic Evaluation of the Traceless Staudinger Ligation for Radiolabeling with the Tricarbonyl Core
por: Constantin Mamat, et al.
Publicado: (2021)

Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes
por: Alessandro Ruggiero, et al.
Publicado: (2010)

Doxorubicin and indocyanine green loaded superparamagnetic iron oxide nanoparticles with PEGylated phospholipid coating for magnetic resonance with fluorescence imaging and chemotherapy of glioma
por: Shen C, et al.
Publicado: (2018)